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Abstract: Few studies have examined the role of maternal diet in relation to development of coeliac
disease (CD). In Denmark, cancellation of mandatory vitamin D fortification of margarine in June 1985
provided this opportunity. This study examined if season of birth or prenatal exposure to extra
vitamin D from food fortification were associated with developing CD later in life. A strength of
this study is the distinctly longer follow-up of patients (30 years). This register-based study has a
semi-ecological design. Logistic regression analysis was used to estimate odds ratios and to calculate
95% confidence intervals. The odds ratio for developing CD was 0.81 (95% CI 0.66; 1.00 p = 0.054),
comparing those with fetal exposure to mandatory vitamin D fortification policy of margarine to
those without after adjusting for gender and season of birth. There was a statistically significant
season effect particularly for children born in autumn (OR 1.6 95% CI 1.16; 2.21) and born in summer
(OR 1.5 95% CI 1.1; 2.1) when compared to children born in winter. Although this study did not
find evidence to support the premise that prenatal exposure to small extra amounts of vitamin D
from a mandatory food fortification policy lowered risk of developing CD, the small number of CD
cases and observed association between season of birth and CD suggest that environmental exposure
ought to be further explored.
Keywords: vitamin D; coeliac disease; fetal programming; season of birth; prenatal exposure;
fortification; D-tect; social experiment; public health epidemiology; ecological study
1. Introduction
There has been an alarming increase over the past 30 years in the prevalence and incidence
of autoimmune diseases, e.g., multiple sclerosis, type 1 diabetes, Crohn’s disease, Graves’ disease,
and coeliac disease (CD) [1]. In Denmark, incidence rates for CD have risen from 1.6 per 100,000
person-years in 1980–1984 to 15.2 per 100,000 person-years in 2015–2016 [2]. Previous prevalence of
CD from the Danish registers has been reported as 50 per 100,000 [3]. However, more recent studies
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have estimated a higher prevalence of between 180 per 100,000 [2] or approximately 500 per 100,000 if
screening and clinical evaluation were part of case identification [3]. Advice for primary prevention of
CD includes breastfeeding and introduction of small amounts of gluten whilst breastfeeding although
studies have not shown that this advice has long-term preventative effects [4,5] The only treatment
available for these patients is an inconvenient and often expensive gluten-free diet [4,6] consisting of
avoiding products containing wheat, barley, oats, and rye.
CD is a particularly unique autoimmune disease because it is well known that gluten (a protein
found in wheat, barley, and rye) drives the dysfunction of the immune system in genetically susceptible
individuals [7]. The reason why some people react to gluten and others do not may be a combination
of genetic predisposition or environmental triggers [4].
The genetics of CD are well established with CD occurring almost exclusively with genotype
HLA (human leucocyte antigens)-DQ2 or HLA-DQ8 haplotypes. The HLA-DQ2 haplotype has been
reported in 90% of patients diagnosed with CD, and the HLA-DQ8 haplotype has been reported in
5% of patients. The remaining 5% of patients have at least one of the two genes encoding DQ2 [6].
Despite, 25–40% of the Caucasian population having these genes, only 2–3% develop CD after intake
of gluten [5,8]. Therefore, the precise triggers for developing CD remain elusive. To date, a variety of
possible triggers have been explored including (i) breastfeeding and infant feeding practices such as
age at gluten exposure and ongoing breastfeeding at gluten exposure, (ii) pregnancy and birth-related
factors including maternal antibiotic use and mode of delivery, (iii) maternal smoking (throughout
pregnancy or never), and (iv) socioeconomic status [4,5,9]. All these factors have been explored using
different types of studies, however, often with conflicting results.
More recently, maternal vitamin D levels have been suggested to have a role in the development
of autoimmune diseases [10,11]. Other studies have shown an association between season of birth or
latitude of place of living and CD [12–17]. These observations have led to a proposition known as the
vitamin D deficiency–CD hypothesis [18]. This hypothesis suggests that maternal vitamin D deficiency
dysregulates a neonate’s immune response in genetically predisposed individuals, resulting in the
development of CD.
Vitamin D has been found to play an important role in promoting immunity by enhancing the innate
immune system and by regulating the adaptive immune system [10,19]. A 2018 randomized control
trial found a stronger innate cytokine response in neonates born from mothers supplemented from
the second trimester with 4400IU/d vitamin D compared to mothers supplemented with 400IU/d [20].
However, two studies in 2017 did not find an association between prenatal vitamin D levels and the risk
of CD [21,22]. The TEDDY study was an international multicenter observational study prospectively
following 8676 children from birth until 15 years of age for environmental factors involved in both type
1 diabetes and CD. Its strengths included a large study population and the prospective multi-center
study design, and weaknesses include the retrospective collection of information on diet intake during
pregnancy and, therefore, the high likelihood of recall bias. The other study was a Norwegian nested
case-control study using the Norwegian Mother and Child Cohort (MoBa), which consisted of 113,053
children. This study assessed 416 children with CD and 570 mother and child pairs as controls selected
randomly from the MoBa cohort. The strengths of this study included repeated assessment of vitamin
D levels, the prospective collection of information on vitamin D intake, and the inclusion of genetic risk
factors. The limitations included possible selection bias, lack of information on sunlight levels, and age
of the population in the cohort being relatively young (CD cases identified up to 7–8 years of age).
On 01 June 1985, the Danish Government abandoned the mandatory fortification program of
adding vitamin D to margarine that had been in place since the mid-1930s. This change in policy
gives a unique opportunity for studying the effect of vitamin D fortification. One such opportunity is
the D-tect research program. This program was initiated to explore if the individual risk of disease
differs between exposed (born during fortification of margarine) or unexposed offspring (born after
fortification of margarine ceased) [23]. If the vitamin D fortification policy had a protective effect for
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the neonate in relation to later development of disease such as CD, it has immediate, cheap, and easy
public health implications and mandatory food fortification in Denmark ought to be reconsidered.
The objectives of this study were as follows:
(i) To investigate if season of birth and the concomitant production of vitamin D from sunlight was
associated with the risk of developing CD
(ii) To investigate if individuals with fetal exposure to extra vitamin D from the mandatory vitamin
D food fortification policy had a decreased risk of developing CD later in life compared to
individuals with no fetal exposure
(iii) To examine if the risk of developing CD related to prenatal exposure to extra vitamin D from the
fortification policy was dependent on season of birth and if risk reduction is potentially stronger
for summer born compared to winter born children
2. Materials and Methods
2.1. Study Design
This was a semi-ecological study [24]. The study examined two cohorts exposed or not exposed to
extra vitamin D from the Danish mandatory fortification policy. This policy stipulated that margarine
was fortified with 1.25 µg vitamin D per 100g margarine. The exposure (maternal exposure to
the fortification policy) is aggregated, exploratory, and global with no distinct measurement on an
individual level. In contrast, the outcome, CD, was identified individually. The date of cancellation of
this policy, 01 June 1985, serves as a time reference point for the creation of the two cohorts [25].
2.2. Study Population
The exposed study population consisted of all children born in Denmark in the two-year period
between 01 June 1983 and 31 May 1985 (these children were exposed to the vitamin D fortification
policy prenatally) and all children in Denmark born in the two year period between 01 September
1986 and 31 August 1988 (these children were not exposed to vitamin D fortification policy prenatally).
Individuals who died or emigrated were excluded. See the flowchart of the study population (Figure 1).
The cohorts were created with a washout period of 15 months, and records of all individuals in the
study population were reviewed over a 30-year period for development of CD.
2.3. Washout Period
The 15-month washout period between the two cohorts consisted of 4 months to account for
normal margarine shelf-life, an additional 2 months to account for margarine stored beyond shelf life,
and a further 9 months to exclude individuals conceived during this 6-month period.
2.4. Sources of Data
The Danish National Patient register (DNPR) was established in 1977 [26,27] and was used to
retrieve information on patients diagnosed with CD using the International Classification of Diseases
(ICD-8 codes 269 until the end of 1993 and thereafter ICD-10 DK900). The Danish Civil Registration
System (CPR) was established in 1968 and assigns a unique 10 digit number to everyone living in
Denmark [28]. This number can be linked to other registries such as DNPR, enabling the study of
large populations [29]. The CPR was used to retrieve information such as death, emigration, gender,
and date of birth of individuals in the entire study population.
2.5. Exposure(s)
Season of birth is a categorical variable classified as follows: winter (November, December,
and January), spring (February, March, and April), summer (May, June, and July), and autumn (August,
September, and October). This categorization is based upon the seasonal fluctuation of vitamin D
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levels in individuals living in high northern latitude countries [30] and is consistent with classification
of seasons from previous D-tect studies based on the same study population.
The abandonment of the mandatory vitamin D fortification policy marks the time point that
separates the cohorts and is a binary categorical variable.
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Figure 1. Flow chart of study population. * Exposed: The Danish population was exposed to the
Danish vitamin D fortification policy. ** Not Exposed: The Danish population was not exposed to the
Danish vitamin D fortification policy.
2.6. Outcome—Coeliac Disease
The outcome, CD diagnosis, is a binary categorical variable. To reduce the risk of false positives,
we defined CD a priori as the occurrence of at least two or more records in the DNPR of ICD-8 code 269
and/or ICD-10 code K900. A previous study reported that the positive predictive value of identifying
CD cases from DNPR if at least two records were used was 73.6–85.6% [31]. For the purposes of this
study, diagnosis of dermatitis herpetiformis, a cutaneous manifestation of CD assisted by a gluten free
diet [32], was not included as a CD outcome.
2.7. Statistical Analysis
A power calculation determined that, with an expected 350 cases of CD among the approximately
222,000 individuals in our study, with significance level of 5%, we have 80% power to detect an odds
ratio of 0.75 from the exposed to the unexposed.
Logistic regression analyses were used to estimate odds ratios and to compute 95% confidence
intervals. Analyses were adjusted for season of birth and sex. A multiplicative interaction between
season of birth and exposure to vitamin D policy was tested by a likelihood ratio test using a 5%
significance level. Sensitivity analyses were completed by changing the case definition to at least one
record of CD in the DNPR and recategorization of seasons to winter (December, January, and February),
spring (March, April, and May), summer (June, July, and August), and autumn (September, October,
and November). All statistical analyses were performed using R version 3.3.3 (R Foundation for
Statistical Computing, Vienna, Austria, www.R-project.org).
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2.8. Ethics
According to Danish law, ethical approval is not required for register-based studies. Permission
to access data was granted by the Danish Health Data Authority. The Centre of excellence in research
in the Capital Region of Denmark provided permission to process the data (VD-2019-237).
3. Results
The total number of children available was 217,249 of which 206,900 were included in the study;
98,856 children were exposed prenatally to the fortification policy, and 108,044 children were not
exposed. Of the exposed children, 148 (0.15%) developed CD during the subsequent 30 years, compared
to 199 (0.18%) of unexposed children (Figure 1). There was a higher number of women than men who
developed CD, with the majority being diagnosed after the age of 15 years (Table 1).
Season of birth was significantly associated with a change in the odds of developing CD,
particularly for subjects born in autumn (OR = 1.60, 95% CI 1.16; 2.21 p = 0.004) and summer (OR = 1.51,
95% CI 1.10; 2.09 p = 0.01) compared to subjects born in winter (Table 2).
The odds ratio for developing CD was 0.81 (95% CI 0.66; 1.00 p = 0.054), comparing those with
fetal exposure to mandatory vitamin D fortification policy of margarine to those without after adjusting
for gender and season of birth (Table 2).
There was no significant interaction between season of birth and the prenatal exposure to the
mandatory vitamin D fortification policy on the odds of developing CD later in life (p = 0.56).
Table 1. Characteristics of population with coeliac disease (CD) compared to those without (N = 206,900).
CD (n = 347) No CD (n = 206,553)
n % n % p–Value 1
Gender <0.001
Women 221 63.7 100,801 48.8
Men 126 36.3 105,752 51.2
Season of birth 0.02
Nov–Jan (winter) 58 16.7 46,696 22.6
Feb–Apr (spring) 83 23.9 52,745 25.5
May–Jul (summer) 103 29.7 55,064 26.7
Aug–Oct (autumn) 103 29.7 52,048 25.2
Age at diagnosis 2 <0.001
<2 years 100 28.8
2–14 years 54 15.6
15+ years 193 55.6
1 Tested using Chi squared test. 2 Based on first record in the Danish National Patient register (DNPR).
Table 2. Risk of coeliac disease among those prenatally exposed to extra vitamin D and dependent on
season of birth.
Odds Ratio 95% CI 1 p–Value
Vitamin D fortification policy 2 0.054
Not exposed (ref) 1
exposed 0.81 0.66; 1.00
Gender <0.001
Women (ref) 1
Men 0.54 0.44; 0.68
Season of birth 3 0.02
Nov–Jan
(winter)(ref) 1
Feb–Apr (spring) 1.28 0.91; 1.78 0.16
May–Jul (summer) 1.51 1.10; 2.09 0.01
Aug–Oct (autumn) 1.60 1.16; 2.21 0.004
1 CI = Confidence interval. 2 Adjusted for sex and season of birth. 3 Adjusted for sex and the vitamin D
fortification policy.
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4. Discussion
This is the first study to report a significant association between season of birth and risk of
developing CD in a Danish population. This is also the first study to report on the association between
prenatal exposure to extra vitamin D from a food fortification policy and the development of CD before
30 years of age.
There was a significant seasonal effect for individuals born in summer and autumn. However,
while the overall results suggested a decreased risk of developing CD of almost 20% for those exposed
prenatally to the extra vitamin D from mandatory fortification, the association was only borderline
significant possibly due to the small number of cases with CD. There was no further benefit of the
extra vitamin D for those born in summer or autumn seasons, where extra vitamin D during the early
“dark” trimesters was hypothesized to have had a benefit.
4.1. Season of Birth and Risk of Developing CD
In this study, subjects born in winter had the lowest odds of developing CD. Inadequate exposure
to sunlight is a major risk factor for vitamin D deficiency [33], and from October through April, where
the ultraviolet B (UVB) radiation is insufficient for vitamin D conversion in the skin [34,35], Danes
have lower vitamin D status and are predisposed to vitamin D deficiency [34]. Indeed, other immune
diseases such as multiple sclerosis have been reported to have a higher prevalence in countries of high
latitude [33]. CD was also reported as more common among people living at higher latitudes in the
US despite adjustment for BMI and demographic factors [17]. It could be reasonably assumed that
children born in summer or autumn in countries of high latitude have been exposed to lower maternal
vitamin D levels in early to mid-gestation due to darker seasonal months in the first half of pregnancy.
This may adversely influence the development of the fetus’ immune system with consequences later in
life [36]. In agreement, earlier studies have reported a lower risk of developing CD for winter-born
compared to summer-born children [12–16,37,38].
Although vitamin D variations provide a possible explanation for the association between CD risk
and season of birth, the timing of weaning and first exposure to gluten in relation to viral load could
also be responsible for the association with season. Indeed, children born in summer/autumn often
begin weaning and have their first exposure to gluten during the winter period, which is characterized
by higher exposure to seasonal viruses. Viral infections influence flora and permeability of the intestine,
and other studies have suggested that this may play a role in the etiology of CD [16,39]. Indeed, a recent
study reported that reovirus infection may trigger CD in some patients [40]. Thus, the development of
viral infections at the time of introduction to gluten may also provide a further or additional explanation
for the association between season of birth and CD.
4.2. Exposure to Extra Vitamin D from Fortification and The Development of CD
Although in the present study the association between prenatal exposure to the extra vitamin D
from mandatory margarine fortification and the development of CD was not significant, the almost
20% reduced odds of CD indicate that there may be a protective effect of vitamin D fortification.
Arguably, both the small extra amount of vitamin D from fortification, which contributed on average
13% of total dietary vitamin D [41], as well as the small number of CD cases in this cohort may have
further contributed to the uncertainty of the fortification effect based on the broad confidence interval.
On the other hand, the inconclusive association found in the present study is supported by findings
from two previous studies that examined the association between prenatal exposure to vitamin D and
development of CD [21,22]. In the case-control study from the Norwegian Mother and Child Cohort
Study (MoBa), the authors reported that there was no association between maternal and neonatal
vitamin D levels and CD [21]. In the longitudinal prospective TEDDY study, maternal use of vitamin
D supplements during pregnancy did not influence the risk of the offspring developing CD [22].
Nutrients 2020, 12, 1243 7 of 11
However, our study had a distinctly longer follow-up (30 years vs 6–8 years) compared to TEDDY
and MoBa [21,22], and although the onset of CD can occur throughout all ages of life, there are two
reported peaks: one in the first 2 years of life and the other after the age of 20 or 30 [42]. Indeed, in our
study, most individuals were diagnosed with CD after 15 years of age (See Table 1) making a direct
comparison with the TEDDY and MoBa study results difficult.
It is difficult to pinpoint an exact timeframe during gestation where vitamin D deficiency may
have the most critical effect on the developing fetus and its immune system. Recent discoveries
have found that the fetal immune system is not simply immature or less responsive than the adult
immune system but has its own specific and unique function [43]. Dendritic cells, crucial for a
well-functioning immune system, have been reported to be fully functional at 13 weeks gestation but
unique as they activate T-cells, suppressing the immune responses to foreign proteins rather than
targeting these foreign proteins for destruction [43]. Vitamin D does have both immunoregulatory
and anti-inflammatory effects on dendritic cells so the critical timeframe could be as early as 13 weeks.
Another study suggested that the period was even earlier and may well be the irreversible critical
period in particular in relation to gene transcription in the placenta and during placentation [44].
A recent randomized control trial exploring the programming of the immune system during fetal
development reported that vitamin D supplementation beginning in the second trimester did modify
the neonates immune system [20]. Much of the previous literature reports that vitamin D can affect the
immune system, but our understanding of how this occurs is only just beginning to evolve [44]. Until
development of the fetal immune system and the modification of genes and cells by nutrients is better
understood, it will be difficult to ascertain accurately whether and when is the most desirable timing
of vitamin D supplementation during pregnancy and the specific disease outcomes that timely vitamin
D supplementation could alleviate.
4.3. Strengths and Limitations
A major strength of this study is the use of valid and complete register data and complete birth
cohorts, ensuring that the results are generalizable to the entire Danish population. The unique long
follow-up and clear definition of cases (minimizing false positives) are other strengths of the study
design. No major societal events have been reported between June 1983 and August 1988 other than
the termination of the vitamin D fortification policy [45,46]. Therefore, adjustment for confounding is
unnecessary as the potential confounding factors are likely to be equally distributed between these
two cohorts. However, residual confounding could occur if a secular trend is overlooked. Some of
these potential trends are as follows:
Sources of vitamin D: The possibility that the two cohorts had different sources of vitamin D
was explored as a potential confounder. However, vitamin D supplementation recommendations for
pregnant women did not change during 1983–1988 [46]. The differences in monthly sunshine hours per
year between 1983–1988 were not significant [47,48]. The consumption of margarine during this period
was remarkably stable [49]. As a result of the above, the assumption has been made that sources of
vitamin D were not different between the two cohorts.
Trends in CD incidence: CD has increased from 1.6 per 100,000 person years to 15.2 per 100,000
person years from 1986 to 2016 in Denmark [2]. This increased incidence in CD may well be the reason
for the higher number of CD cases in unexposed cohort. There is no great difference in the number of
CD cases between the two cohorts despite this increasing incidence, and therefore, the conclusion in
relation to the lack of association between fortification and risk of CD is strengthened.
Major societal incident: The nuclear accident (Chernobyl) that occurred 26 April 1986 (during
washout period) in the north of Ukraine may have increased the disease burden of the unexposed
cohort. Denmark was one of the first countries to receive fallout from Chernobyl, but contamination
was relatively modest due to the absence of precipitation when the first cloud passed the country [50].
This incident also strengthens our conclusion that exposure prenatally to fortification had no effect on
Nutrients 2020, 12, 1243 8 of 11
risk of developing CD as the disease burden from such an accident would be expected to increase the
strength of the association.
Apart from these secular trends, another significant limitation was that individual vitamin D
levels were not assessed. This is a limitation of a register study with an aggregated exposure that
cannot be measured on an individual level. Other limitations include the fact that the number of true
cases in this study were most likely underestimated and that there were potential unaccounted false
negative cases. In fact, despite this study’s long follow-up period of 30 years, the individuals who
developed CD in their late 20s would not necessarily have had the two records required to be defined
as a CD case before the age of 30 and, therefore, may not have been identified in the study. Therefore,
despite following individuals for 30 years, the follow-up period may still have been a limiting factor.
Prevalence of CD is higher by a factor of 10 if diagnosed via screening and clinical detection compared
to prevalence based on register-based data [3], indicating that CD is mainly treated in the primary care
system and/or is underdiagnosed in Denmark. We therefore performed a sensitivity analysis where
the case definition was redefined to individuals who had a minimum of one record of CD in the DNPR.
However, despite this change, there was still no significant association between prenatal exposure
to the fortification policy and risk of developing CD (see Table S1). This supported the finding of
no association between prenatal exposure to mandatory vitamin D fortification policy and risk of
developing CD. Studies from D-tect define seasons according to sunlight variation, while some other
seasonal studies use a slightly different definition. Therefore, a sensitivity analysis was completed
with re-categorized seasons (see Table S2).
5. Conclusions
Although this study did not find evidence to support the premise that prenatal exposure to small
extra amounts of vitamin D from a mandatory food fortification policy lowered risk of developing
CD, the small number of CD and observed association between season of birth and CD suggest that
environmental exposure ought to be further explored.
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